Search

everythinglearnresearchcommunity

for

Search:↓

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Women with mild acne are more likely to have polycystic ovary syndrome (PCOS) than those without acne.

Oriental herbal medicine with moxibustion may improve pregnancy rates and other symptoms in PCOS, but more high-quality research is needed.

A combined drug and laser treatment improved hirsutism in a PCOS patient, also enhancing her heart health and requiring regular liver and kidney checks.

Unwanted facial hair significantly impacts over 40% of women's psychological and social well-being, and various treatment options are available.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

The Nd:YAG laser safely reduces facial hair and slows regrowth, with patient satisfaction.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

Metformin helped improve the quality of life for Chinese women with PCOS, especially in physical health and symptoms like infertility, acne, and hair loss.

People with Inflammatory Bowel Disease often lose hair due to stress, medication side effects, or lack of nutrients, and treatment depends on the specific cause.

Treating hirsutism in women often requires a mix of medications and cosmetic methods for best results.

Flutamide works better than finasteride for hirsutism, and combining both is slightly better but not much.

Larger ovarian size is linked to higher insulin resistance in women with PCOS.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Treating excessive hair in women requires a holistic approach, including medical, aesthetic, and emotional support.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

The Chinese version of the PCOS quality of life questionnaire is reliable and valid for Chinese-speaking women with PCOS.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

The entry showed that PCOS negatively affects women's self-image and is worsened by societal expectations, suggesting a need for more feminist attention to the condition.

Many adults in Porto have acne, but few know or treat it.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

Alternative treatments show promise for hair growth beyond traditional methods.

Pediatric dermatologists need to understand the unique skin health needs of LGBTQIA youth to provide better care.